医学
生活质量（医疗保健）
卵巢癌
背景（考古学）
疾病
化疗
肿瘤科
妇科癌症
癌症
内科学
妇科
生物
古生物学
护理部
作者
Yeh Chen Lee,Madeleine Trudy King,Rachel L. O’Connell,Anne Lanceley,Florence Joly,Felix Hilpert,Alison J. Davis,Felicia T. Roncolato,Aikou Okamoto,Jane Bryce,Paul P. Donnellan,Amit M. Oza,Elisabeth H. Åvall-Lundqvist,Jonathan S. Berek,Jonathan Andrew Ledermann,Dominique Berton-Rigaud,Jalid Sehouli,Amanda Feeney,Marie‐Christine Kaminsky,Katrina Diamante
标识
DOI：10.1097/ogx.0000000000001075
摘要
(Abstracted from Int J Gynecol Cancer 2022;32:761–768) Patients with recurrent ovarian cancer often experience a multitude of symptoms related to disease progression and the cumulative toxicities from multiple treatment regimens. The goals of chemotherapy in this context include palliating symptoms, improving health-related quality of life (HRQL), and delaying disease progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
null
无极微光
kaio_escolar
啦啦
invisight
v0id
DW
含蓄觅山
极限001
乐空思
地球合适爆炸
GingerF
aaaa
舒服的楷瑞
Elsevier大王
学术文献互助
初景
木头人
庄园在逃害人精
舒适的如萱
皖公网安备34019202002308
